Friday, November 29, 2024

KP Tissue Releases Second Quarter 2016 Financial Results

 August 10, 2016 - 7:00 AM EDT

Print

Email Article

Font Down

Font Up

KP Tissue Releases Second Quarter 2016 Financial Results

Q2 Adjusted EBITDA increased 18.9%

MISSISSAUGA, ONTARIO--(Marketwired - Aug. 10, 2016) - KP Tissue Inc. (KPT) (TSX:KPT) reports the Q2 2016 financial and operational results of KPT and Kruger Products L.P. (KPLP). Kruger Products is Canada's leading manufacturer of quality tissue products for the Consumer market (Cashmere®, Purex®, SpongeTowels®, Scotties®, and White Swan®) and the Away-From-Home market, and continues to grow in the U.S. Consumer tissue business with the White Cloud® brand and premium private label products. KPT currently holds a 16.2% interest in KPLP.

KPLP Q2 2016 Business and Financial Highlights

  • Revenue increased by 5.9% to $295.8 million in Q2 2016 compared to Q2 2015
  • Adjusted EBITDA was $35.9 million in Q2 2016 compared to $30.2 million in Q2 2015, up 18.9%
  • Foreign exchange negative impact of approximately $1 million on Adjusted EBITDA over the previous year
  • Continue to be the market share leader in Canada
  • Declared a quarterly dividend of $0.18 per share to be paid on October 17, 2016
  • Announced on July 25 a new paper machine investment in Quebec of $55 million

"A combination of several favourable factors resulted in a very solid Adjusted EBITDA performance for the quarter, one of our highest levels since going public. The Consumer segment was the main driver of our Adjusted EBITDA growth of 18.9% over last year," said Mario Gosselin, CEO of KPT and KPLP.

"For the quarter, the impact of foreign exchange remained a negative factor on Adjusted EBITDA but was offset by higher sales driven primarily by promotional activities, lower pulp and natural gas costs, and the benefit of higher selling prices in the Canadian consumer market which positively impacted the latter part of the quarter. Adjusted EBITDA from TAD products in the U.S. was slightly higher, while Away-from-Home declined slightly.

"For the third quarter, while we anticipate continued benefits from higher selling prices in Canada, the industry remains quite competitive. Consequently, we expect third quarter 2016 Adjusted EBITDA to be higher than the second quarter of 2016," concluded Mr. Gosselin.

KPLP Q2 2016 Financial Results

Revenue in Q2 2016 was $295.8 million, compared to $279.3 million in Q2 2015, an increase of $16.5 million or 5.9%. The increase in revenue was primarily due to higher sales volumes, the favourable impact of foreign exchange on U.S. dollar sales, and a selling price increase in Canada.

Cost of sales in Q2 2016 increased to $249.9 million compared to $240.4 million in Q2 2015, primarily due to higher sales volumes and the negative impact of foreign exchange fluctuations and increased warehousing costs, partially offset by a decline in USD pulp and natural gas prices. As a percentage of revenue, cost of sales were 84.5% in Q2 2016 compared to 86.1% in Q2 2015.

Selling, general and administrative (SG&A) expenses in Q2 2016 were $22.0 million compared to $21.3 million in Q2 2015. The increase was primarily due to higher sales volumes and the unfavourable impact of foreign exchange. As a percentage of revenue, SG&A expenses decreased to 7.4% in Q2 2016 from 7.6% in Q2 2015.

Adjusted EBITDA in Q2 2016 was $35.9 million compared to $30.2 million in Q2 2015 due to higher sales and lower USD costs for pulp and natural gas, partially offset by higher warehousing and SG&A costs from increased sales, and the net negative impact of foreign exchange. Adjusted EBITDA attributable to the sale of KTG's TAD products was $12.0 million in Q2 2016 compared to $11.2 million in Q2 2015.

Net income in Q2 2016 was $12.0 million compared to $3.2 million in Q2 2015 primarily due to higher Adjusted EBITDA of $5.7 million, a pension revaluation related to past service cost of $3.4 million in Q2 2015, lower amortized cost of the Partnership unit liability of $1.9 million, and a decrease in interest expense of $1.6 million. These items were partially offset by an increase in depreciation expense of $2.7 million, a decrease in the unrealized foreign exchange gain of $0.6 million, and restructuring costs of $0.4 million.

Total liquidity, representing cash and cash equivalents and availability under the credit line within covenant limitations, was $77.8 million as of June 26, 2016 compared to $58.5 million as of March 27, 2016.

KPT Q2 2016 Financial Results

KPT incurred a net loss of $0.6 million in Q2 2016. Included in the net loss was $2.0 million representing KPT's share of KPLP's income. The income was reduced by depreciation expense of $1.5 million related to adjustments to carrying amounts on acquisition and income tax expense of $1.3 million.

Dividends on Common Shares

The Board of Directors of KPT declared a quarterly dividend of $0.18 per share to be paid on October 17, 2016 to shareholders of record at the close of business on September 30, 2016.

Additional Information

For additional information please refer to Management's Discussion and Analysis (MD&A) of KPT and KPLP for the second quarter ended June 26, 2016 available on SEDAR at www.sedar.com or our website at www.kptissueinc.com.

Second Quarter Results Conference Call Information

KPT will hold its second quarter conference call on Wednesday, August 10, 2016 at 8:30 a.m. Eastern Time.

Via telephone: 1-877-223-4471 or 647-788-4922

Via the internet at: www.kptissueinc.com

Presentation material referenced during the conference call will be available at www.kptissueinc.com.

A rebroadcast of the conference call will be available until midnight, September 9, 2016 by dialing 800-585-8367 or 416-621-4642 and entering passcode 46381716.

The replay of the webcast will remain available on the website until midnight, September 9, 2016.

About KP Tissue Inc. (KPT)

KPT was created to acquire, and its business is limited to holding, a limited partnership interest in KPLP, which is accounted for as an investment on the equity basis. KPT currently holds a 16.2% interest in KPLP. For more information visit www.kptissueinc.com.

About Kruger Products L.P. (KPLP)

KPLP is Canada's leading manufacturer of quality tissue products for household, industrial and commercial use. KPLP serves the Canadian consumer market with such well-known brands as Cashmere®, Purex®, SpongeTowels®, Scotties® and White Swan®. In the U.S., KPLP manufactures the White Cloud® brand, as well as many private label products. The Away-From-Home division manufactures and distributes high-quality, cost-effective product solutions to a wide range of commercial and public entities. KPLP has approximately 2,500 employees and operates seven production facilities in North America, including five FSC® CoC- certified mills (FSC® C104904), four of which are located in Canada and one in the U.S. For more information visit www.krugerproducts.ca.

Non-IFRS Measures

This press release uses certain non-IFRS financial measures which KPLP believes provide useful information to management of KPLP and the readers of the financial information in measuring the financial performance and financial condition of KPLP. These measures do not have a standardized meaning prescribed by IFRS and therefore may not be comparable to similarly titled measures presented by other companies. An example of such a measure is Adjusted EBITDA. Beginning with Q4 2015 in accordance with Canadian Securities Administrators Staff Notice 52-306 (Revised), we reference Adjusted EBITDA as a non-IFRS financial measure. This term replaces the previously referenced non-IFRS financial measure EBITDA. Our definition of Adjusted EBITDA is unchanged from our former definition of EBITDA. Accordingly, this change in terminology has no impact on our reported financial results for prior periods. Adjusted EBITDA is not a measurement of operating performance computed in accordance with IFRS and should not be considered as a substitute for operating income, net income or cash flows from operating activities computed in accordance with IFRS. "Adjusted EBITDA" is calculated by KPLP as net income (loss) before (i) interest expense, (ii) income taxes, (iii) depreciation, (iv) amortization, (v) impairment (recovery) of non-financial assets, (vi) loss (gain) on disposal of property, plant and equipment, (vii) unrealized foreign exchange loss (gain), (viii) costs related to restructuring activities, (ix) changes in the amortized cost of the Partnership units liability, and (x) one-time costs due to pension revaluations related to past service. A reconciliation of Adjusted EBITDA to the relevant reported results can be found in the MD&A of KPT and KPLP for the second quarter ended June 26, 2016 available on SEDAR at www.sedar.com.

Forward-Looking Statements

Certain statements in this press release about KPT's and KPLP's current and future plans, expectations and intentions, results, levels of activity, performance, goals or achievements or any other future events or developments constitute forward-looking statements. The words "may", "will", "would", "should", "could", "expects", "plans", "intends", "trends", "indications", "anticipates", "believes", "estimates", "predicts", "likely" or "potential" or the negative or other variations of these words or other comparable words or phrases, are intended to identify forward-looking statements. The forward-looking information is based on certain key expectations and assumptions made by KPT, including expectations and assumptions concerning the impact of the TAD Project on Adjusted EBITDA, the expectation of continued growth in sales of TAD products in the U.S., and stable interest rates. Although KPT believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information since no assurance can be given that such expectations and assumptions will prove to be correct.

The outlook provided in respect of Adjusted EBITDA for Q3 2016 is forward-looking information and is subject to the risk and uncertainties referred to below. The purpose of the outlook is to provide the reader with an indication of management's expectations, at the date of this press release, regarding KPLP's future financial performance. Readers are cautioned that this information may not be appropriate for other purposes. 

Many factors could cause KPLP's actual results, level of activity, performance or achievements or future events or developments (which could in turn affect the economic benefits derived from the Corporation's economic interest in KPLP) to differ materially from those expressed or implied by the forward-looking statements, including, without limitation, the following factors, which are discussed in greater detail in the "Risk Factors - Risks Related to KPLP's Business" section of the KPT Annual Information Form dated March 10, 2016 available on SEDAR at www.sedar.com: Kruger Inc.'s influence over KPLP; KPLP's reliance on Kruger Inc.; consequences of an event of insolvency relating to Kruger Inc.; risks associated with the TAD Project; operational risks; Gatineau Plant land lease; significant increases in input costs; reduction in supply of fibre; increased pricing pressure and intense competition; KPLP's inability to innovate effectively; adverse economic conditions; dependence on key retail trade customers; damage to the reputation of KPLP or KPLP's brands; KPLP's sales being less than anticipated; KPLP's failure to implement its business and operating strategies; KPLP's obligation to make regular capital expenditures; KPLP's entering into unsuccessful acquisitions; KPLP's dependence on key personnel; KPLP's inability to retain its existing customers or obtain new customers; KPLP's loss of key suppliers; KPLP's failure to adequately protect its intellectual property rights; KPLP's reliance on third party intellectual property licenses; adverse litigation and other claims affecting KPLP; material expenditures due to comprehensive environmental regulation affecting KPLP's cash flow; KPLP's pension obligations are significant and can be materially higher than predicted if KPLP Management's underlying assumptions are incorrect; labour disputes adversely affecting KPLP's cost structure and KPLP's ability to run its plants; exchange rate and U.S. competitors; KPLP's inability to service all of its indebtedness; exposure to potential consumer product liability, restrictive covenants; interest rate and refinancing risk; information technology and innovation; insurance; and internal controls.

Readers should not place undue reliance on forward-looking statements made herein. The forward-looking information contained herein is expressly qualified in its entirety by this cautionary statement. The forward-looking information contained herein is made as of the date of press release and KPT undertakes no obligation to publicly update such forward-looking information to reflect new information, subsequent or otherwise, unless required by applicable securities laws.

Kruger Products L.P.  
Unaudited Condensed Consolidated Statement of Financial Position  
(thousands of Canadian dollars)  
         
  June 26, 2016   December 31, 2015  
  $   $  
Assets        
Current assets        
  Cash and cash equivalents 10,104   25,455  
  Trade and other receivables 108,178   108,720  
  Receivables from related parties 455   185  
  Current portion of advances to partners 5,465   2,630  
  Inventories 183,925   184,985  
  Income tax recoverable 593   772  
  Prepaid expenses 9,752   8,429  
  318,472   331,176  
Non-current assets        
  Advances to partners -   4,234  
  Property, plant & equipment 729,693   737,708  
  Other long-term assets 6,839   8,107  
  Goodwill 160,939   160,939  
  Intangible assets 15,344   15,853  
  Deferred income taxes 37,906   39,411  
Total assets 1,269,193   1,297,428  
         
Liabilities        
Current liabilities        
  Trade and other payables 188,026   180,329  
  Payables to related parties 5,084   3,775  
  Distributions payable 10,016   9,871  
  Current portion of provisions 2,471   3,096  
  Current portion of long-term debt 9,148   10,183  
  214,745   207,254  
Non-current liabilities        
  Long-term debt 408,420   425,859  
  Other long-term liabilities 16   48  
  Provisions 6,583   6,180  
  Pensions 127,047   87,164  
  Post-retirement benefits 59,405   57,346  
  Liabilities to non-unitholders 816,216   783,851  
  Current portion of Partnership units liability 2,630   2,630  
  Long-term portion of Partnership units liability 121,148   122,546  
  Total Partnership units liability 123,778   125,176  
Total liabilities 939,994   909,027  
         
Equity        
  Partnership units 327,021   318,012  
  Deficit (76,510 ) (29,416 )
  Accumulated other comprehensive income 78,688   99,805  
Total equity 329,199   388,401  
Total equity and liabilities 1,269,193   1,297,428  
         
         
   
Kruger Products L.P.  
Unaudited Condensed Consolidated Statement of Comprehensive Income (Loss)  
(thousands of Canadian dollars)  
                 
  13-week   13-week   26-week   26-week  
  period ended   period ended   period ended   period ended  
  June 26, 2016   June 28, 2015   June 26, 2016   June 28, 2015  
  $   $   $   $  
                 
Revenue 295,757   279,337   575,447   544,713  
                 
Expenses                
  Cost of sales 249,878   240,413   490,525   462,953  
  Selling, general and administrative expenses 21,986   21,277   43,638   42,896  
  Restructuring costs 393   -   393   1,054  
                 
Operating income 23,500   17,647   40,891   37,810  
                 
  Interest expense 10,921   12,473   22,135   22,815  
  Other (income) expense (291 ) 1,167   (1,120 ) 5,949  
                 
Income before income taxes 12,870   4,007   19,876   9,046  
                 
Income taxes 834   832   1,450   1,161  
                 
Net income for the period 12,036   3,175   18,426   7,885  
                 
Other comprehensive income (loss)                
  Items that will not be reclassified to net income:                
  Remeasurements of pensions (27,120 ) 11,368   (43,889 ) (6,038 )
  Remeasurements of post-retirement benefits (1,755 ) 1,503   (1,634 ) (2,149 )
  Items that may be subsequently reclassified to net income:                
  Available-for-sale investment -   222   (290 ) (29 )
  Cumulative translation adjustment (6,846 ) (7,213 ) (20,827 ) 16,664  
                 
Total other comprehensive income (loss) for the period (35,721 ) 5,880   (66,640 ) 8,448  
                 
Comprehensive income (loss) for the period (23,685 ) 9,055   (48,214 ) 16,333  
                 
                 
   
Kruger Products L.P.  
Unaudited Condensed Consolidated Statement of Cash Flows  
(thousands of Canadian dollars)  
                 
  13-week   13-week   26-week   26-week  
  period ended   period ended   period ended   period ended  
  June 26, 2016   June 28, 2015   June 26, 2016   June 28, 2015  
  $   $   $   $  
Cash flows from (used in) operating activities                
Net income for the period 12,036   3,175   18,426   7,885  
Items not affecting cash                
  Depreciation 11,681   9,234   21,768   18,978  
  Amortization 296   174   580   337  
  Loss (gain) on sale of fixed assets (4 ) (26 ) (3 ) 139  
  Change in amortized cost of Partnership units liability -   1,850   1,234   3,162  
  Gain on sale of investment -   -   (324 ) -  
  Unrealized foreign exchange (gain) loss (291 ) (946 ) (2,030 ) 2,352  
  Interest expense 10,921   12,473   22,135   22,815  
  Pension and post retirement benefits 2,659   6,096   5,318   8,776  
  Provisions 658   358   799   1,691  
  Income taxes 834   832   1,450   1,161  
  Total items not affecting cash 26,754   30,045   50,927   59,411  
                 
Net change in non-cash working capital 12,177   (6,075 ) (4,462 ) (29,484 )
Contributions to pension and post-retirement benefit plans (5,462 ) (3,768 ) (11,305 ) (7,402 )
Provisions paid (642 ) (442 ) (1,118 ) (707 )
Income tax payments (508 ) (451 ) (1,373 ) (1,006 )
                 
Net cash from operating activities 44,355   22,484   51,095   28,697  
                 
Cash flows from (used in) investing activities                
Purchases of property, plant & equipment (22,512 ) (8,192 ) (38,701 ) (17,654 )
Proceeds on sale of investment -   -   1,439   -  
Government assistance received -   -   1,209   -  
Purchases of software (2 ) (39 ) (71 ) (204 )
Proceeds on sale of property, plant and equipment 4   96   4   282  
                 
Net cash used in investing activities (22,510 ) (8,135 ) (36,120 ) (17,576 )
                 
Cash flows from (used in) financing activities                
Proceeds from long-term debt -   -   791   -  
Repayment of long-term debt (306 ) (306 ) (7,510 ) (510 )
Payment of deferred financing fees (5 ) -   (335 ) -  
Interest paid on long-term debt (8,737 ) (3,324 ) (9,756 ) (10,539 )
Distributions and advances paid (5,530 ) (7,111 ) (12,077 ) (17,522 )
Proceeds from issuing partnership units -   -   -   195  
                 
Net cash used in financing activities (14,578 ) (10,741 ) (28,887 ) (28,376 )
                 
Effect of exchange rate changes on cash and cash equivalents held in foreign currency (1,143 ) (292 ) (1,439 ) 740  
                 
Increase (decrease) in cash and cash equivalents during the period 6,124   3,316   (15,351 ) (16,515 )
                 
Cash and cash equivalents - Beginning of period 3,980   31,957   25,455   51,788  
                 
Cash and cash equivalents - End of period 10,104   35,273   10,104   35,273  
                 
                 
   
Kruger Products L.P.  
Segment and Geographic Results  
(thousands of Canadian dollars)  
                 
  13-week   13-week   26-week   26-week  
  period ended   period ended   period ended   period ended  
  June 26, 2016   June 28, 2015   June 26, 2016   June 28, 2015  
  $   $   $   $  
                 
Segment Information                
                 
Segment Revenue                
  Consumer 232,395   217,045   460,546   427,195  
  AFH 59,051   57,438   108,102   105,997  
  Other 4,311   4,854   6,799   11,521  
                 
Total segment revenue 295,757   279,337   575,447   544,713  
                 
Segment Adjusted EBITDA                
  Consumer 34,063   29,122   62,066   59,419  
  AFH 1,431   2,055   1,265   3,023  
  Other 372   (995 ) 622   (1,143 )
                 
Total segment Adjusted EBITDA 35,866   30,182   63,953   61,299  
                 
Reconciliation to Net Income:                
                 
Depreciation and amortization 11,977   9,408   22,348   19,315  
Interest expense 10,921   12,473   22,135   22,815  
Change in amortized cost of Partnership units liability -   1,850   1,234   3,162  
(Gain) loss on sale of fixed assets (4 ) (26 ) (3 ) 139  
Pension revaluation - past service cost -   3,416   -   3,416  
Restructuring costs 393   -   393   1,054  
Unrealized foreign exchange (gain) loss (291 ) (946 ) (2,030 ) 2,352  
                 
Income before income taxes 12,870   4,007   19,876   9,046  
                 
Income taxes 834   832   1,450   1,161  
                 
Net income 12,036   3,175   18,426   7,885  
                 
Geographic Revenue                
                 
Canada 179,974   180,809   345,859   344,202  
U.S. 102,906   90,427   204,579   183,805  
Mexico 12,877   8,101   25,009   16,706  
                 
Total revenue 295,757   279,337   575,447   544,713  
                 
                 
   
KP Tissue Inc.  
Unaudited Condensed Statement of Financial Position  
(thousands of Canadian dollars)  
         
  June 26, 2016   December 31, 2015  
  $   $  
Assets        
         
Current assets        
  Distributions receivable 1,624   1,613  
  Income tax recoverable 897   828  
  2,521   2,441  
         
Non-current assets        
  Investment in associate 111,544   126,643  
         
Total Assets 114,065   129,084  
         
Liabilities        
         
Current liabilities        
  Dividend payable 1,624   1,613  
  Payable to Partnership 207   108  
  Current portion of advances from Partnership 914   432  
  2,745   2,153  
Non-current liabilities        
  Advances from Partnership -   709  
  Deferred income taxes 1,365   1,007  
         
Total liabilities 4,110   3,869  
         
Equity        
         
  Common shares 12,258   11,577  
  Contributed surplus 144,819   144,819  
  Deficit (60,985 ) (49,291 )
  Accumulated other comprehensive income 13,863   18,110  
         
Total equity 109,955   125,215  
         
Total liabilities and equity 114,065   129,084  
         
         
   
KP Tissue Inc.  
Unaudited Condensed Statement of Comprehensive Income (Loss)  
(thousands of Canadian dollars, except share and per share amounts)  
                 
  13-week   13-week   26-week   26-week  
  period ended   period ended   period ended   period ended  
  June 26, 2016   June 28, 2015   June 26, 2016   June 28, 2015  
  $   $   $   $  
                 
Equity income (loss) 469   (909 ) 91   (1,567 )
                 
Dilution gain 255   37   84   122  
                 
Income (loss) before income taxes 724   (872 ) 175   (1,445 )
                 
Income taxes 1,329   75   2,258   139  
                 
Net loss for the period (605 ) (947 ) (2,083 ) (1,584 )
                 
Other comprehensive income (loss)                
  net of tax expense (recovery)                
  Items that will not be reclassified to net loss:                
  Remeasurements of pensions (3,829 ) 1,631   (6,209 ) (864 )
  Remeasurements of post-retirement benefits (174 ) 151   (162 ) (216 )
  Items that may be subsequently reclassified to net loss:                
  Available-for-sale investment -   32   (41 ) (4 )
  Cumulative translation adjustment (1,675 ) (296 ) (4,206 ) 3,115  
                 
Total other comprehensive income (loss) for the period (5,678 ) 1,518   (10,618 ) 2,031  
                 
Comprehensive income (loss) for the period (6,283 ) 571   (12,701 ) 447  
                 
Basic loss per share (0.07 ) (0.11 ) (0.23 ) (0.18 )
                 
Weighted average number of shares outstanding 9,016,939   8,894,391   9,005,511   8,883,295  
                 
                 
   
KP Tissue Inc.  
Unaudited Condensed Statement of Cash Flows  
(thousands of Canadian dollars)  
                 
  13-week   13-week   26-week   26-week  
  period ended   period ended   period ended   period ended  
  June 26, 2016   June 28, 2015   June 26, 2016   June 28, 2015  
  $   $   $   $  
Cash flows from (used in) operating activities                
Net loss for the period (605 ) (947 ) (2,083 ) (1,584 )
Items not affecting cash                
  Equity (income) loss (469 ) 909   (91 ) 1,567  
  Dilution gain (255 ) (37 ) (84 ) (122 )
  Income taxes 1,329   75   2,258   139  
  Total items not affecting cash 605   947   2,083   1,584  
                 
Tax payments -   (307 ) (205 ) (1,097 )
Tax distribution received -   -   -   571  
Advances received -   307   205   526  
                 
Net cash from (used in) operating activities -   -   -   -  
                 
Cash flows from (used in) investing activites                
Investment in associate -   -   -   (195 )
Partnership unit distributions received 935   1,209   2,548   2,804  
                 
Net cash from investing activities 935   1,209   2,548   2,609  
                 
Cash flows from (used in) financing activities                
Issuance of common shares -   -   -   195  
Dividends paid (935 ) (1,209 ) (2,548 ) (2,804 )
                 
Net cash used in financing activities (935 ) (1,209 ) (2,548 ) (2,609 )
                 
Increase (decrease) in cash and cash equivalents during the period -   -   -   -  
                 
Cash and cash equivalents - Beginning of period -   -   -   -  
                 
Cash and cash equivalents - End of period -   -   -   -  
                 

Francois Paroyan
General Counsel and Corporate Secretary
KP Tissue Inc.
905.812.6936
francois.paroyan@krugerproducts.ca

INVESTORS:
Mike Baldesarra
Director of Investor Relations
KP Tissue Inc.
905.812.6962
IR@KPTissueinc.com

Source: Marketwired
(August 10, 2016 - 7:00 AM EDT)

News by QuoteMedia

www.quotemedia.com

Share: